23AndMe Completes $27.8 Million Series B Round
Personal genomics startup 23andMe has recently raised another $14.2 million to close out its $27.8 million Series B round, according to regulatory filings with the SEC. The filing indicates that the new funding is an amendment to the company’s previously reported raise of $11 million in May, which was followed by an additional $2.6 million in June. We’ve reached out to 23andMe to confirm the funding amount, and to also determine if there are any new investors. Update: 23andMe have confirmed that they’ve raised funding, but have not yet confirmed the amount.
The last few months have been rocky for the company. In September, co-founder Linda Avey left 23andMe to start a foundation dedicated to studying Alzheimer?s disease. In late October, the company laid off a substantial chunk of its workforce, but declined to comment on how many people were affected.
» Read whole article at techcrunch.com ...